Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study.

JHEP Rep · 2026 · PMC13199667 · PMID 41903606

Europe PMC DOI

hedged sentence

0.0860

closest p · 1.7× alpha

0.0860

boldest claim

The sentences

did not reach statistical significancep = 0.086so close (0.05 < p ≤ 0.1)

At M24 of the overall treatment duration, VR rates were numerically higher in patients with ≥48 weeks of add-on treatment; however, this effect did not reach statistical significance (100.0% vs. 58.3%; p = 0.086).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.